Metrikler
Yayın
60
Açık Erişim
10
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2013 - 2016
2013 - 2016Tıpta Yandal Uzmanlık
Hacettepe Üniversitesi, Türkiye
2007 - 2011
2007 - 2011Tıpta Uzmanlık
Hacettepe Üniversitesi, Türkiye
1999 - 2006
1999 - 2006Lisans
İstanbul Bilim Üniversitesi, Tıp Fakültesi, Türkiye
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Araştırma Alanları
Onkoloji
Akademik Ünvanlar / Görevler
2018 - Devam Ediyor
2018 - Devam EdiyorDoç. Dr.
Hacettepe Üniversitesi, Kanser Enstitüsü, Klinik Onkolojisi A.B.D.
Akademi Dışı Deneyim
2016 - 2018
2016 - 2018UZMAN DOKTOR
RİZE EĞİTİM ARAŞTIRMA HASTANESİ, UZMAN DOKTOR
2011 - 2013
2011 - 2013UZMAN DOKTOR
ANKARA ULUS DEVLET HASTANESİ, UZMAN DOKTOR
2007 - 2007
2007 - 2007PRATİSYEN HEKİM
YUKARIŞEYHLER SAĞLIK OCAĞI ÇERMİK/ DİYARBAKIR, PRATİSYEN HEKİM
2006 - 2007
2006 - 2007ARAŞTIRMA GÖREVLİSİ
KOCAELİ ÜNİVERSİTESİ TIP FAKÜLTESİ TIBBİ PATOLOJİ ABD, ARAŞTIRMA GÖREVLİSİ
Makaleler
Tümü (48)
SCI-E, SSCI, AHCI (41)
SCI-E, SSCI, AHCI, ESCI (44)
ESCI (2)
Scopus (46)
TRDizin (6)
Diğer Yayınlar (1)
2025
20251. Fear of Cancer Recurrence and Associated Factors in Lymphoma Survivors and Their Family Caregivers: A Cross-Sectional Study
ŞAHİN T. K., Sahin E. A., Gungor H. N., GÜVEN D. C., BARIŞTA İ., AKIN S.
CANCER MEDICINE
, sa.7, 2025 (SCI-Expanded, Scopus)
2025
20252. Serum Albumin-Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer
BAŞ O., Guduk N., Tokatli M., Guven D. C., ÖZER N., ŞENER Y. Z., et al.
JOURNAL OF CLINICAL MEDICINE
, sa.5, 2025 (SCI-Expanded, Scopus)
2025
20253. The Role of Radiotherapy in Indolent Ocular Adnexal and Orbital Lymphomas
YAZICI G., AKIN S., KAHVECİOĞLU A., YİĞİT E., TÜRKER F. A., YILDIZ F.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
, sa.3, ss.891-898, 2025 (SCI-Expanded, Scopus)
2025
20254. Evaluating Immunotherapy Responses in Neuro-Oncology for Glioblastoma and Brain Metastases: A Brief Review Featuring Three Cases
KERTMEN N., KAVGACI G., AKIN S., ÇOBAN ÇİFÇİ G., IŞIKAY A. İ., YAZICI G.
CANCER CONTROL
, 2025 (SCI-Expanded, Scopus)
2024
20245. Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management
AKYILDIZ A., Ismayilov R., Rustamova N., Tokatli M., KOÇ İ., AKIN S., et al.
Annals of Hematology
, cilt.103, sa.3, ss.905-915, 2024 (SCI-Expanded, Scopus)
2024
20246. Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation
Ucgul E., Guven D. C., Ucgul A. N., ÖZBAY Y., ONUR M. R., AKIN S.
CANCER CONTROL
, cilt.31, 2024 (SCI-Expanded, Scopus)
2024
20247. Bilateral Testicular Plasmacytoma Preceding Multiple Myeloma with Extramedullary Renal Involvement: A Case Report
KAVGACI G., KÖKSAL B., ARIK Z., BARIŞTA İ., AKIN S.
PLASMATOLOGY
, cilt.18, 2024 (ESCI, Scopus)
2023
20238. Bilgisayarlı Tomografi, Pozitron Emisyon Tomografisi ve Nükleer Manyetik Rezonans Görüntülemede Temel Kavram ve İlkeler.
BAYARI S. H., AKIN S., TUNCEL M.
Batı Karadeniz Tıp Degisi
, cilt.7, sa.3, ss.269-278, 2023 (TRDizin)
2023
20239. Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future
Srour S. A., AKIN S.
Journal of Immunotherapy and Precision Oncology
, cilt.6, sa.1, ss.19-30, 2023 (Scopus)
2023
202310. A Novel Tumor Marker for Anaplastic Lymphoma Kinase (+) Lymphoma: Beta-Human Chorionic Gonadotropin
Moral K., SEYHAN E., KUTLAY D. Y., AKIN S.
Journal of Oncological Science
, cilt.9, sa.1, ss.46-49, 2023 (Scopus, TRDizin)
2022
202211. Bilateral primary breast lymphoma in a pregnant woman: a case report and literature review
YILDIRIM H. Ç., AKYILDIZ A., Ismayilov R., Demirok N., BENLİ B. S., Guven D. C., et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY
, cilt.15, sa.4, ss.307-310, 2022 (ESCI, Scopus)
2022
202212. SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research
GÜVEN D. C., Sahin T. K., AKIN S., Uckun F. M.
ONCOLOGIST
, cilt.27, sa.11, 2022 (SCI-Expanded, Scopus)
2022
202213. Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination
GÜVEN D. C., Sahin T. K., AKIN S., Uckun F. M.
ONCOLOGIST
, cilt.27, 2022 (SCI-Expanded, Scopus)
2022
202214. Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement
Akin S., Hosing C., Khouri I., Ahmed S., Alousi A., Fowler N., et al.
BLOOD ADVANCES
, cilt.6, sa.7, ss.2267-2274, 2022 (SCI-Expanded, Scopus)
2020
202015. Comparison of clinical and PET-derived prognostic factors in patients with non-Hodgkin lymphoma: a special emphasis on bone marrow involvement
Kupik O., Akin S., Tuncel M., Eren G., Türker A., Kars A., et al.
NUCLEAR MEDICINE COMMUNICATIONS
, cilt.41, sa.6, ss.540-549, 2020 (SCI-Expanded, Scopus)
2020
202016. Gemcitabine, Oxaliplatin and Paclitaxel (GemPOx ) in Patients with Relapsed or Refractory Germ Cell Tumors After High Dose Chemotherapy, A Retrospective Single-Center Experience
Acar R., Erturk I., Kiziloz H., Okcelik S., Yildiz B., Aykan M. B., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.30, sa.4, ss.191-196, 2020 (SCI-Expanded, Scopus, TRDizin)
2019
201917. Efficacy of Pazopanib in patients with metastatic uterine sarcoma: A multi-institutional study
Sunar V., Korkmaz V., AKIN S., GÜVEN D. C., ARIK Z., Ates O., et al.
JOURNAL OF BUON
, cilt.24, sa.6, ss.2327-2332, 2019 (SCI-Expanded, Scopus)
2018
201818. Association between androgen receptor status and prognosis in triple negative breast cancer
Sunar V., Dogan H. T., Sarici F., ATEŞ Ö., AKIN S., BAŞPINAR B., et al.
JOURNAL OF BUON
, cilt.23, sa.5, ss.1325-1330, 2018 (SCI-Expanded, Scopus)
2018
201819. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma
AKIN S., DİZDAR Ö., KARAKAS Y., Turker A., Kars A.
CURRENT PROBLEMS IN CANCER
, cilt.42, sa.3, ss.344-349, 2018 (SCI-Expanded, Scopus)
2017
201720. Farklı Trombositopeni Sebeplerinin Klinik ve Laboratuvar Bulguları
AKIN S., AKIN Ş., Karaağaç A. T., HAZNEDAROĞLU İ. C.
Journal of Contemporary Medicine
, cilt.7, sa.4, ss.316-322, 2017 (Hakemli Dergi)
2017
201721. Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms
AKIN S., DİZDAR Ö., Hayran M.
ANNALS OF SURGICAL ONCOLOGY
, cilt.24, 2017 (SCI-Expanded, Scopus)
2017
201722. Evaluation of complementary and alternative medicine trials registered in clinicaltrials.gov database
DİZDAR Ö., BİLGİN E., AKIN S., KILIÇKAP S., HAYRAN M.
JOURNAL OF BUON
, cilt.22, sa.2, ss.530-534, 2017 (SCI-Expanded, Scopus)
2017
201723. Prediction of central lymph node metastasis in patients with thyroid papillary microcarcinoma
Akin S., Aksoy D. Y., AKIN S., KILIÇ M., Yetisir F., BAYRAKTAR M.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.47, sa.6, ss.1723-1727, 2017 (SCI-Expanded, Scopus, TRDizin)
2016
201624. Symptomatic Adrenal Insufficiency due to Bilateral Adrenal Non-Hodgkin’s Lymphoma
AKIN Ş., Akın S., TUNCEL M., ERSÖZ G. N.
Turkish Journal of Endocrinology and Metabolism , cilt.20, ss.108-110, 2016 (Scopus, TRDizin)
2016
201625. Left laterality is an independent prognostic factor for metastasis in N3 stage breast cancer
Karatas F., Sahin S., Erdem G. U., ATEŞ Ö., BABACAN T., AKIN S., et al.
JOURNAL OF BUON
, cilt.21, sa.4, ss.851-858, 2016 (SCI-Expanded, Scopus)
2016
201626. Correlation of educational status and clinicopathological characteristics of breast cancer: a single center experience
Sarici F., BABACAN T., Buyukhatipoglu H., Balakan O., SEVER A. R., KERTMEN N., et al.
JOURNAL OF BUON
, cilt.21, sa.4, ss.826-831, 2016 (SCI-Expanded, Scopus)
2016
201627. Trastuzumab 1-year vs 9-week in early-stage HER2-positive, lymph node negative breast cancer patients
Ozen M., Gunduz M., ATEŞ Ö., BABACAN T., SEVER A. R., AKIN S., et al.
JOURNAL OF BUON
, cilt.21, sa.4, ss.799-808, 2016 (SCI-Expanded, Scopus)
2016
201628. Interpretation of survival data: which graphical analysis is appropriate?
Dizdar O., AKIN S., HAYRAN M.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
, cilt.8, sa.4, ss.312, 2016 (SCI-Expanded, Scopus)
2016
201629. Analysis of the Adjuvant Hormone Therapy Randomized Trial
Karakas Y., AKIN S., DİZDAR Ö., AKSOY S.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.34, sa.17, ss.2070-2071, 2016 (SCI-Expanded, Scopus)
2016
201630. Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer
ATEŞ Ö., BABACAN T., KERTMEN N., Sarici F., Cenoli A., AKIN S., et al.
JOURNAL OF BUON
, cilt.21, sa.2, ss.375-381, 2016 (SCI-Expanded, Scopus)
2016
201631. Leg cramps associated with tamoxifen use - possible mechanism and treatment recommendations
Karatas F., Sahin S., BABACAN T., AKIN S., SEVER A. R., Altundag K.
JOURNAL OF BUON
, cilt.21, sa.2, ss.520, 2016 (SCI-Expanded, Scopus)
2016
201632. Vaccination Attitudes Among Patients with Cancer Receiving Chemotherapy
AKIN S., DİZDAR Ö., ÖZIŞIK L., TANRIOVER M., KAMISLI S., ERMAN M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.3, ss.167-172, 2016 (SCI-Expanded, Scopus, TRDizin)
2015
201533. Insomnia caused by aromatase inhibitors; a therapeutic challenge in patients with breast cancer
Karatas F., Sahin S., BABACAN T., AKIN S., SEVER A. R., Altundag K.
JOURNAL OF BUON
, cilt.20, sa.6, ss.1640, 2015 (SCI-Expanded, Scopus)
2015
201534. Does eribulin mesylate cause recurrent transient diplopia?
Karatas F., Hacioglu B., AKIN S., BABACAN T., SEVER A. R., Altundag K.
JOURNAL OF BUON
, cilt.20, sa.5, ss.1379, 2015 (SCI-Expanded, Scopus)
2015
201535. Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER2-negative breast cancer
BABACAN T., Efe O., Hasirci A. S., Demirci F., Buyukhatipoglu H., Balakan O., et al.
TUMORI J
, cilt.101, sa.4, ss.418-423, 2015 (SCI-Expanded, Scopus)
2015
201536. Can aromatase inhibitors cause forgetfulness in women with breast cancer ?
Karatas F., AKIN S., BABACAN T., SEVER A. R., Altundag K.
JOURNAL OF BUON
, cilt.20, sa.3, ss.935, 2015 (SCI-Expanded, Scopus)
2015
201537. Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis
BABACAN T., Buyukhatipoglu H., Balakan O., KERTMEN N., Suner A., Sarici F., et al.
JOURNAL OF BUON
, cilt.20, sa.2, ss.479-486, 2015 (SCI-Expanded, Scopus)
2015
201538. How long should we maintain anti-HER2 therapy for metastatic breast cancer patients with complete remission?
Hacioglu B., AKIN S., BABACAN T., SEVER A. R., Altundag K.
FUTURE ONCOLOGY
, cilt.11, sa.20, ss.2799-2801, 2015 (SCI-Expanded, Scopus)
2015
201539. Which sequence best protects the heart against trastuzumab and anthracycline toxicity An electron microscopy study in rats
KERTMEN N., AKSOY S., ÜNER A., ÖZGÜR Ö., keskin o., babacan t., et al.
Anticancer Research
, 2015 (SCI-Expanded, Scopus)
2015
201540. Comparison of three different induction regimens for nasopharyngeal cancer
KERTMEN N., AKSOY S., CENGİZ M., YAZICI G., KESKİN O., Babacan T., et al.
Asian Pacific Journal of Cancer Prevention
, cilt.16, sa.1, ss.59-63, 2015 (SCI-Expanded, Scopus)
2015
201541. Clinical implications of intratumoral heterogeneity ofHER2gene amplification in locally advanced HER2-positive breast cancer patients
Hacioglu B., AKIN S., SEVER A. R., Altundag K.
FUTURE ONCOLOGY
, cilt.11, sa.18, ss.2495-2497, 2015 (SCI-Expanded, Scopus)
2015
201542. Molecular subtypes in patients with inflammatory breast cancer; A single center experience
KERTMEN N., BABACAN T., Keskin O., Solak M., Sarici F., AKIN S., et al.
JOURNAL OF BUON
, cilt.20, sa.1, ss.35-39, 2015 (SCI-Expanded, Scopus)
2015
201543. Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab
ATEŞ Ö., Sunar V., BABACAN T., AKIN S., KERTMEN N., Altundag K.
JOURNAL OF BUON
, cilt.20, sa.1, ss.349, 2015 (SCI-Expanded, Scopus)
2014
201444. Acute erythroid leukemia in a patient with chronic lymphocytic leukemia
GÜVEN D. C., BABACAN T., Sarici F., AKIN S., Altundag K., Turker A.
JOURNAL OF BUON
, cilt.19, sa.4, ss.1127, 2014 (SCI-Expanded, Scopus)
2014
201445. Breast sarcoma: A rare malignancy
Gul G., BABACAN T., AKIN S., Sarici F., Altundag K.
JOURNAL OF BUON
, cilt.19, sa.2, ss.577, 2014 (SCI-Expanded, Scopus)
2014
201446. A novel targeted therapy in breast cancer: Cyclin dependent kinase inhibitors
AKIN S., BABACAN T., Sarici F., Altundag K.
JOURNAL OF BUON
, cilt.19, sa.1, ss.42-46, 2014 (SCI-Expanded, Scopus)
2012
201247. Nasopharyngeal sarcoidosis: a rare involvement
Akin S., Akin S., KARADAĞ Ö., KALYONCU U., Balci S., ÖZGEN MOCAN B.
RHEUMATOLOGY INTERNATIONAL
, cilt.32, sa.5, ss.1407-1409, 2012 (SCI-Expanded, Scopus)
2010
201048. Concomitant renal cell carcinoma and lymphoid malignancies: a case series of five patients and review of the literature
Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., Akin S. C., Akin S., SAYINALP N., et al.
MEDICAL ONCOLOGY
, cilt.27, sa.1, ss.55-58, 2010 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2025
20251. Kemoterapi Tedavisi Gören Kanser Hastalarında Fiziksel Aktivite ile Sağlık Okuryazarlığı, Yaşam Kalitesi ve Sosyal Destek Algısı Arasındaki İlişkinin Araştırılması
Karakaş O., İmece A. M., KUMBAROĞLU F. B., AKIN S., ATASAVUN UYSAL S.
19. ULUSLARARASI FİZYOTERAPİDE GELİŞMELER KONGRESİ, Ankara, Türkiye, 09 Nisan 2025, (Özet Bildiri)
2018
20182. The Role of FDG PET/CT Detecting Bone Marrow Involvement in Non-Hodgkin's Lymphoma Patients
KUPIK O., Akin S., TUNCEL M., TÜRKER A., Kars A., Erbas B.
31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Almanya, 13 - 17 Ekim 2018, cilt.45, (Özet Bildiri)
2016
20163. The impact of the total size of lesions in multifocal multicentric breast cancer on survival
Karakaş Y., DİZDAR Ö., Akın S., ATEŞ Ö., ŞENDUR M. A. N., AKSOY S., et al.
2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016, (Tam Metin Bildiri)
2016
20164. Clinicopathologic characteristics of patients with recurrent or metastatic synovial sarcoma
ATEŞ Ö., AKSOY S., YETER H. H., Akın S., KERTMEN N., DİZDAR Ö., et al.
2016 ASCO Annual Meeting, 29 Mayıs - 03 Haziran 2016, (Tam Metin Bildiri)
2016
20165. The impact of the total size of lesions in multifocal/multicentric breast cancer on survival.
Karakas Y., Dizdar O., Akin S., Ates O., Sendur M. A. N., Aksoy S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34, (Özet Bildiri)
2015
20156. Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer
Ateş Ö., Babacan T., SARICI F., KERTMEN N., CENOLİ A., Akın S., et al.
ASCO Annual Meeting, 29 Mayıs - 02 Haziran 2015, (Tam Metin Bildiri)
2015
20157. Correlation of educational status and clinicopathological characteristics of breast cancer: A single center experience.
Diker O., Babacan T., Buyukhatipoglu H., Kertmen N., Balakan O., Sever A. R., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2015
20158. Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER-2 negative breast cancer.
Altundag K., Babacan T., Efe O., Hasirci A. S., Demirci F., Buyukhatipoglu H., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2015
20159. Signet ring cell carcinoma of breast: Single center experience.
AKIN S., DIKER O., KERTMEN N., ATEŞ Ö., DİZDAR Ö., YALÇIN Ş., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2014
201410. Which sequence prevents the heart from trastuzumab and anthracycline toxicity: Electron microscopy study in rats
Aksoy S., Kertmen N., ÜNER A., Sargon M., Ozkayar O., Keskin O., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
201411. Comparison of three different induction regimen in nasopharyngeal cancer: CF versus DC versus DCF.
Kertmen N., Aksoy S., Cengiz M., Yazici G., Keskin O., Babacan T., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
201412. Is there any correlation between molecular subtypes and blood groups in breast cancer?
Kucukoztas N., Oguz A., Babacan T., Dizdar O., Rahatli S., Sarici S. F., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)